Ad is loading...
SMVSX
Price
$29.70
Change
+$0.34 (+1.16%)
Updated
Nov 22 closing price
VISVX
Price
$51.30
Change
+$0.69 (+1.36%)
Updated
Nov 22 closing price
Ad is loading...

SMVSX vs VISVX

Header iconSMVSX vs VISVX Comparison
Open Charts SMVSX vs VISVXBanner chart's image
Invesco Small Cap Value R6
Price$29.70
Change+$0.34 (+1.16%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$51.30
Change+$0.69 (+1.36%)
VolumeN/A
CapitalizationN/A
SMVSX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SMVSX vs. VISVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMVSX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. SMVSX (6.49B). VISVX pays higher dividends than SMVSX: VISVX (1.90) vs SMVSX (0.70). SMVSX was incepted earlier than VISVX: SMVSX (8 years) vs VISVX (27 years). SMVSX is a more actively managed with annual turnover of: 51.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than SMVSX: VISVX (3000) vs SMVSX (1000000). SMVSX annual gain was more profitable for investors over the last year : 39.79 vs. VISVX (30.04). SMVSX return over 5 years is better than : 101.38 vs. VISVX (62.14).
SMVSXVISVXSMVSX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD30.95517.712175%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets6.49B57.6B11%
Annual Yield % from dividends0.701.9037%
Returns for 1 year39.7930.04132%
Returns for 3 years26.9516.92159%
Returns for 5 years101.3862.14163%
Returns for 10 yearsN/A109.83-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics